• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 3. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenyl-1,3-oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles Phenyl-1,3-oxazoles

Recent Advances in the Study of 4-(chloromethyl)-2-(2-fluorophenyl)-5-methyl-1,3-oxazole (CAS: 671215-76-2)

4-(Chloromethyl)-2-(2-fluorophenyl)-5-methyl-1,3-oxazole (CAS: 671215-76-2) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. This compound, characterized by its oxazole core and fluorophenyl substituent, serves as a versatile intermediate for the synthesis of various biologically active molecules. Recent studies have explored its utility in the design of kinase inhibitors, antimicrobial agents, and other therapeutic candidates, highlighting its importance in modern pharmaceutical research.

One of the key areas of investigation has been the role of 4-(chloromethyl)-2-(2-fluorophenyl)-5-methyl-1,3-oxazole in the synthesis of kinase inhibitors. Kinases are critical targets in cancer therapy, and the structural features of this compound make it an attractive scaffold for developing selective inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this oxazole exhibited potent inhibitory activity against EGFR (epidermal growth factor receptor) mutants, which are often implicated in non-small cell lung cancer (NSCLC). The study reported IC50 values in the nanomolar range, suggesting high efficacy and specificity.

In addition to its applications in oncology, this compound has also been investigated for its antimicrobial properties. A recent publication in Bioorganic & Medicinal Chemistry Letters (2024) described the synthesis of novel oxazole derivatives using 4-(chloromethyl)-2-(2-fluorophenyl)-5-methyl-1,3-oxazole as a key intermediate. These derivatives showed promising activity against drug-resistant strains of Staphylococcus aureus and Escherichia coli, with minimal cytotoxicity to human cells. The researchers attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis, a mechanism distinct from that of traditional antibiotics.

Another notable advancement is the use of 4-(chloromethyl)-2-(2-fluorophenyl)-5-methyl-1,3-oxazole in the development of fluorescent probes for biological imaging. A 2024 study in Chemical Communications highlighted its utility as a building block for near-infrared (NIR) probes, which are valuable tools for in vivo imaging and diagnostics. The probe exhibited high stability and selectivity for tumor tissues, enabling real-time monitoring of cancer progression in preclinical models. This application underscores the compound's versatility beyond traditional drug development.

Despite these promising findings, challenges remain in the optimization of 4-(chloromethyl)-2-(2-fluorophenyl)-5-methyl-1,3-oxazole-based compounds. Issues such as metabolic stability, bioavailability, and off-target effects need to be addressed to translate these discoveries into clinical applications. Ongoing research is focused on structural modifications to enhance these properties while retaining the compound's biological activity. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate progress in this area.

In conclusion, 4-(chloromethyl)-2-(2-fluorophenyl)-5-methyl-1,3-oxazole (CAS: 671215-76-2) represents a valuable scaffold in chemical biology and medicinal chemistry, with diverse applications ranging from kinase inhibition to antimicrobial therapy and biological imaging. Recent studies have demonstrated its potential in addressing unmet medical needs, particularly in oncology and infectious diseases. Future research will likely explore its utility in other therapeutic areas, further solidifying its role in drug discovery and development.

• 61152-06-5(4-Oxazolecarbonyl chloride, 2-(4-fluorophenyl)-5-methyl-)
• 52169-88-7(4-Oxazolecarbonyl chloride, 2-(2-fluorophenyl)-5-methyl-)
• 103788-61-0(4-Chloromethyl-5-methyl-2-phenyl-oxazole)
• 832076-92-3(Oxazole, 4-(chloromethyl)-2-(4-chlorophenyl)-5-methyl-)
• 671215-81-9(4-(chloromethyl)-5-methyl-2-(2-methylphenyl)-1,3-oxazole)
• 61152-05-4(4-Oxazolecarbonyl chloride, 2-(3-fluorophenyl)-5-methyl-)
• 832076-91-2(Oxazole, 2-[1,1'-biphenyl]-4-yl-4-(chloromethyl)-5-methyl-)
• 137090-44-9(4-(Chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole)
• 521266-92-2(4-(Chloromethyl)-5-methyl-2-(3-methylphenyl)-1,3-oxazole)
• 625826-69-9(4-Chloromethyl-2-(4-fluoro-phenyl)-5-methyl-oxazole)